MG
Michael Gladstone
OtherQuietPartner at Atlas Venture
4
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Michael Gladstone.
Investment Thesis & Strategy
Michael Gladstone, as a partner at Atlas Venture, invests in various stages of biotech and pharmaceutical companies, seeking to support innovative ventures within the life sciences sector.
Investment Activity
Deals per year over the last 6 years
2
20160
20170
20181
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 4 companies
T
Third Harmonic Bio
Biotech · Series A, 2021
X
Xilio Therapeutics
Biotech · Series B, 2019
S
Spero Therapeutics
Biotech · Series A, 2016
S
Surface Oncology
Biotech · Series B, 2016
Frequently Asked Questions
Michael Gladstone focuses on Series B stage investments.